PROCEPT BioRobotics Corporation (NASDAQ: PRCT) reported Q3 EPS of ($0.40), $0.09 better than the analyst estimate of ($0.49). Revenue for the quarter came in at $58.37 million versus the consensus estimate of $53.3 million.

For earnings history and earnings-related data on PROCEPT BioRobotics Corporation (PRCT) click here.